Indivior Pharmaceuticals INDV Balance Sheet (2021-2026)

NASDAQ INDV
$34.01 -0.31 (-0.89%)
As of: Sep 9, 2026 · 12:53 PM EDT
Reported Financials

Indivior Pharmaceuticals Quarterly Balance Sheet

Periods 13 quarters
Latest Jun 2026

Indivior Pharmaceuticals reported total assets of $1233.00M and total liabilities of $1441.00M for the quarter ended Jun 2026, down 15.1% year over year. This balance sheet covers 13 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 1,102.00M774.00M316.00M319.00M372.00M510.00M445.00M195.00M175.00M222.00M
Short-term InvestmentsInvestments (Current) 119.00M415.00M1.00M1.00M
Cash & Current Investments 1,102.00M893.00M731.00M320.00M373.00M510.00M445.00M195.00M175.00M222.00M
Receivables - NetNet Receivables 202.00M220.00M254.00M254.00M243.00M240.00M259.00M253.00M273.00M271.00M
Receivables - OtherOther Receivables 1.00M2.00M2.00M
Receivables 202.00M220.00M255.00M256.00M243.00M240.00M259.00M255.00M273.00M271.00M
Inventory 95.00M114.00M126.00M167.00M163.00M149.00M155.00M153.00M152.00M150.00M
Prepaid Assets 52.00M31.00M56.00M28.00M30.00M34.00M40.00M54.00M
Current Assets 1,444.00M1,259.00M1,257.00M827.00M883.00M951.00M922.00M652.00M667.00M725.00M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 388.00M510.00M84.00M100.00M104.00M117.00M124.00M144.00M157.00M162.00M
Long-Term Investments 41.00M27.00M27.00M27.00M28.00M28.00M27.00M27.00M
Goodwill 5.00M2.00M2.00M2.00M
Goodwill & Intangibles 82.00M70.00M13.00M2.00M6.00M7.00M7.00M2.00M2.00M2.00M2.00M
Long-Term Deferred Tax 105.00M219.00M286.00M277.00M279.00M270.00M285.00M323.00M296.00M271.00M
Other Non-Current Assets 106.00M38.00M36.00M39.00M39.00M44.00M27.00M27.00M26.00M24.00M
Non-Current Assets -1444.00M-1259.00M501.00M489.00M492.00M501.00M494.00M549.00M530.00M508.00M
Assets 1,758.00M1,316.00M1,375.00M1,452.00M1,416.00M1,201.00M1,197.00M1,233.00M
Liabilities
Current Liabilities
Accounts Payables 720.00M617.00M195.00M216.00M183.00M196.00M215.00M250.00M178.00M206.00M
Notes Payables 3.00M3.00M3.00M
Payables 723.00M620.00M198.00M216.00M183.00M196.00M215.00M250.00M178.00M206.00M
Accumulated Expenses 492.00M99.00M105.00M105.00M106.00M42.00M14.00M14.00M
Other Accumulated Expenses 40.00M11.00M3.00M
Short term Debt 3.00M3.00M3.00M18.00M18.00M18.00M18.00M29.00M
Current Leases 9.00M10.00M11.00M11.00M10.00M10.00M9.00M9.00M
Current Taxes 7.00M9.00M8.00M7.00M12.00M17.00M4.00M2.00M26.00M30.00M
Total Current Liabilities 804.00M1,019.00M1,281.00M924.00M1,005.00M1,056.00M965.00M914.00M779.00M868.00M
Non-Current Liabilities
Non-Current Debt 239.00M237.00M237.00M315.00M311.00M308.00M304.00M290.00M486.00M487.00M
Operating Leases 44.00M37.00M34.00M32.00M30.00M29.00M24.00M22.00M14.00M13.00M
Other Non-Current Liabilities 474.00M428.00M359.00M365.00M297.00M299.00M300.00M52.00M41.00M42.00M
Total Non-Current Liabilities 825.00M699.00M649.00M1,287.00M1,363.00M1,410.00M1,323.00M1,248.00M1,300.00M1,399.00M
Total Liabilities 1,629.00M1,718.00M1,942.00M161.00M281.00M310.00M1,652.00M1,660.00M1,709.00M1,623.00M1,300.00M1,341.00M1,441.00M
Shareholder's Equity
Total Debt 245.00M243.00M243.00M333.00M329.00M326.00M322.00M319.00M486.00M487.00M
Common Equity 121.00M-15.00M-184.00M-161.00M-281.00M-310.00M-337.00M-285.00M-257.00M-207.00M-98.00M-144.00M-208.00M
Liabilities and Shareholders Equity 1,758.00M1,316.00M1,375.00M1,452.00M1,416.00M1,201.00M1,197.00M1,233.00M
Retained Earnings 1,438.00M1,303.00M-288.00M-443.00M-406.00M-388.00M-346.00M-243.00M-280.00M-334.00M